- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Kathleen Lokay on Educating Patients on Treatment Options
Kathleen Lokay, president and CEO of Via Oncology, encourages physicians to educate patients on clinical pathways and discusses how the patient voice is heard.
Kathleen Lokay, president and CEO of Via Oncology, encourages physicians to educate patients on clinical pathways and discusses how the patient voice is heard.
Transcript
Do you have patients involved in the pathways program process to include patient preferences?
Not so much in the sense that we don’t really have patient-facing tools, but what we do provide to our customers is patient education around the drugs to help the patients understand the risk versus benefits of the regiment. But the patient’s voice is really brought to the table through the physicians.
We don’t actually have patients on our committees and it’s not that we are opposed to that it’s just that the committees are very, very scientific. We have reached out and engaged many of the patient advocacy foundations to really try to have them be partners in understanding how we go about representing the patient voice. Ultimately, it’s up to the physician, and we would encourage physicians when talking to patients share the pathway with them, let them see why the pathway recommends this or that and even discuss with them maybe why that patient doesn’t fit the pathway and therefore, should be off pathway. That’s certainly something every physician should do anytime they are meeting with their patient and discussing treatment decisions.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More
